Improved Medication and Care to Achieve Lipid Targets After Carotid Surgery
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorBarmherzige Brüder Linz
About this trial
The goal of this clinical trial is to find out if patients who receive extra support stay on their cholesterol-lowering therapy and therefore have lower cholesterol levels after 4 months. Extra support means regular phone calls and close monitoring before and after carotid artery surgery. The study compares this approach to usual care.
Participants will:
Be randomly assigned to either standard care or extra support for 4 months. Receive cholesterol-lowering treatment and attend follow-up visits.
Eligibility criteria
Qualifiers
Age >17 years
Diagnosed carotid artery stenosis
Planned carotid endarterectomy
LDL cholesterol >55 mg/dL
Disqualifiers
Ongoing treatment with PCSK9 inhibitors
Carotid surgery for reasons other than stenosis (e.g., traumatic injury)
Trial design
Treatments tested in this trial
- Prompt Medication Adjustment and Intensive Follow-up
- Standard Care
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Barmherzige Brüder Linz
Lead sponsor
Johannes Kepler University of Linz
Collaborator
Source ClinicalTrials.gov